睡眠障碍在COVID-19大流行期间非常普遍,尤其是老年人。我们旨在评估COVID-19大流行期间的睡眠健康,并评估地理区域和大流行时期之间的差异。我们搜索了三个数据库(PubMed,Embase,WebofScience)查找截至2023年3月12日的文章。我们纳入了观察性研究,这些研究报告了在任何情况下60岁或以上的成年人中睡眠障碍的患病率。两名研究人员独立回顾了文献并检索了数据。我们使用DerSimonian-Laird随机效应荟萃分析来汇集数据,其次是亚组分析,敏感性分析,和元回归。共纳入了64项研究,其中有181,224名老年人在大流行期间。睡眠质量差的患病率,睡眠时间短,睡眠时间长,失眠症状为47.12%(95%CI:25.97%,68.27%),40.81%(95%CI:18.49%,63.12%),31.61%(95%CI:24.83%,38.38%),和21.15%(95%CI:15.30%,27.00%),分别。自建项目报告的睡眠问题患病率为26.97%(95%CI:20.73%,33.22%)。与美国(64.13%)相比,欧洲(20.23%)和西太平洋(21.31%)的睡眠问题患病率较低(P均<0.0001)。睡眠问题恶化的患病率为27.88%(95%CI:11.94%,43.82%)。与2020年(15.14%)相比,2021年上升至47.42%(P<0.05)。纳入了672例老年COVID-19患者睡眠障碍的8项研究。老年COVID-19患者睡眠问题和失眠症状的患病率为41.58%(95%CI:21.97%,61.20%)和41.56%(95%CI:28.11%,58.02%),分别。在过去的三年中,全球老年人都观察到了与睡眠不良相关的重大负担。不同地区和时间段的变化。重要的是要在预防和干预方面做出更多的努力,以识别危险因素,治疗,和睡眠障碍的康复,以促进健康的衰老。
Sleep disturbances are highly prevalent during the
COVID-19 pandemic, especially among older adults. We aimed to evaluate sleep heath during
COVID-19 pandemic and assess the differences among geographical regions and pandemic periods. We searched three databases (PubMed, Embase, Web of Science) to find articles up to March 12, 2023. We included observational studies that reported the prevalence of sleep disturbances among adults aged 60 years or older in any setting. Two researchers independently reviewed the literature and retrieved the data. We used Der Simonian-Laird random effects meta-analyses to pool the data, followed by subgroup analysis, sensitivity analysis, and meta-regression. A total of 64 studies with 181,224 older adults during the pandemic were included. The prevalence of poor sleep quality, short sleep duration, long sleep duration, and insomnia symptoms were 47.12% (95% CI: 25.97%, 68.27%), 40.81% (95% CI: 18.49%, 63.12%), 31.61% (95% CI: 24.83%, 38.38%), and 21.15% (95% CI: 15.30%, 27.00%), respectively. The prevalence of sleep problems reported by self-constructed items was 26.97% (95% CI: 20.73%, 33.22%). When compared to America (64.13%), Europe (20.23%) and the Western Pacific (21.31%) showed a lower prevalence of sleep problems (all P < 0.0001). The prevalence of worsened sleep problems was 27.88% (95% CI: 11.94%, 43.82%). Compared to 2020 (15.14%), it increased to 47.42% in 2021 (P < 0.05). Eight studies on sleep disturbances among 672 older
COVID-19 patients were included. The prevalence of sleep problems and insomnia symptoms among older
COVID-19 patients were 41.58% (95% CI: 21.97%, 61.20%) and 41.56% (95% CI: 28.11%, 58.02%), respectively. A significant burden related to poor sleep has been observed among older adults worldwide over the past three years, with variations across different regions and time periods. It is important to make more efforts in prevention and intervention to identify the risk factors, treatment, and rehabilitation of sleep disturbances for healthy aging.